Multiplikator Forward P/S: Stereotaxis (STXS)

Stereotaxis, Inc. - logo grafis emiten STXS

Is the Stereotaxis, Inc. (STXS) business shielded from external political shocks? Global deliveries of cardiac robots hold humanitarian status, while cash flow stability is ensured by the sale of consumables. The projected P/S of the business on the GURU.Markets chart confirms the value of high-precision magnetic systems, with the 2.70 value capturing the metric level and underscoring technological leadership in minimally invasive cardiology.

stereotaxis.com - Kapitalisasi marang prakiraan pendapatan STXS (periode 04.07.2022 - 13.11.2026)

Ringkesan rincian data analitis Stereotaxis Corporation (STXS)

- rega pasar lan target rega analis:
Analisis fundamental perusahaan:STXS (Stereotaxis)
Sampel barang Stereotaxis Corporation

Forward P/S determines the market value of an asset relative to projected sales volume, allowing investors to assess the premium paid for expected revenue in real-time. By analyzing the forward P/S trend, one can identify optimal entry points for capital investment in Stereotaxis, Inc. (STXS), whose unique robotic systems for cardiac surgery ensure high surgical precision and fundamental brand stability.

Karo sapa Stereotaxis, Inc. saingan

Rasio rega marang prakiraan pendapatan Boston Scientific Corporation BSX|EW - Multiplikator forward rega marang pendapatan|ResMed Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Insulet Inc.|ZBH: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan COO|ALGN (Align Technology) - Multiplikator Forward P/S|Globus Medical Inc (GMED) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S TMDX|Multiplikator forward rega marang pendapatan Alphatec Corp ATEC|Multiplikator Forward P/S AORT (Artivion, Inc.)|Multiplikator Forward P/S enovis.com ENOV|IART - Rasio rega marang prakiraan pendapatan|ESTA: Rasio rega marang prakiraan pendapatan|BBNX (Beta Bionics Corp) - Multiplikator forward rega marang pendapatan|IRADIMED Inc. - Rega forward marang dodolan|EMBC (Embecta Corp.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep tandemdiabetes.com TNDM|Rasio rega marang prakiraan pendapatan Axogen (AXGN)|SI-BONE Inc (SIBN) - Prakiraan rega marang pendapatan|Orthofix International - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Bioventus Global BVS|OrthoPediatrics Inc. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake treace.com TMCI|Strata Critical Medical (SRTA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CARL (Carlsmed, Inc.)|Rasio rega marang prakiraan pendapatan RxSight Corp|Multiplikator forward rega marang pendapatan ClearPoint (CLPT)|Multiplikator Forward P/S STIM|SGHT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Orchestra BioMed, Inc. OBIO|ANIK: Kapitalisasi marang prakiraan pendapatan|NSPR: Multiplikator forward rega marang pendapatan|Jin Medical International - Rasio rega marang pendapatan sing dikarepake|vivani.com (VANI) - Rasio rega marang prakiraan pendapatan|XTNT - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan NMTC|MODD (Modular Med) - Rasio rega marang pendapatan sing dikarepake|Multiplikator Forward P/S MYO|COCH - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Vivos Therapeutics VVOS|Rega forward marang dodolan NVNO|SINTX Technologies - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Tenon Medical Inc.|ReWalk Robotics Ltd (LFWD) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Autonomix Medical (AMIX)|Multiplikator forward rega marang pendapatan IVF|BBLG (bonebiologics.com) - Rasio rega marang pendapatan sing dikarepake|Multiplikator Forward P/S AXNX|Multiplikator Forward P/S BIOLASE Inc. (BIOL)|Dynatronics - Multiplikator forward rega marang pendapatan|FNA: Kapitalisasi marang prakiraan pendapatan|INVO Bio - Multiplikator Forward P/S